HIBERCELL Trademark

Trademark Overview

On Tuesday, April 5, 2022, a trademark application was filed for HIBERCELL with the United States Patent and Trademark Office. The USPTO has given the HIBERCELL trademark a serial number of 97347567. The federal status of this trademark filing is REGISTERED as of Tuesday, November 18, 2025. This trademark is owned by HiberCell, Inc.. The HIBERCELL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
hibercell

General Information

Serial Number97347567
Word MarkHIBERCELL
Filing DateTuesday, April 5, 2022
Status700 - REGISTERED
Status DateTuesday, November 18, 2025
Registration Number8033052
Registration DateTuesday, November 18, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment of cancer
Description of MarkThe mark consists of the term "HiberCell" in stylized characters. The letters "H" and "C" are capitalized, and the remainder of the letters are represented in lower-case characters. There is a semi-circular design extending over and extending below the letters "r" and "e".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2022
Primary Code005
First Use Anywhere DateThursday, September 26, 2024
First Use In Commerce DateThursday, September 26, 2024

Trademark Owner History

Party NameHiberCell, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameHiberCell, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameHiberCell, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Friday, April 8, 2022NEW APPLICATION ENTERED
Monday, April 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 12, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, January 23, 2023ASSIGNED TO EXAMINER
Friday, January 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 1 FILED
Monday, October 23, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 8, 2024SOU EXTENSION 2 FILED
Monday, April 8, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 4, 2024SOU EXTENSION 3 FILED
Monday, November 4, 2024SOU EXTENSION 3 GRANTED
Monday, November 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 2, 2025TEAS STATEMENT OF USE RECEIVED
Monday, September 29, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 2, 2025USE AMENDMENT FILED
Monday, September 29, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, October 27, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 27, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 18, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, November 18, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

hibercell cancer treatment preparations pharmaceutical